AT270069B - Verfahren zur Herstellung einer injizierbaren Influenzavaccinezubereitung - Google Patents

Verfahren zur Herstellung einer injizierbaren Influenzavaccinezubereitung

Info

Publication number
AT270069B
AT270069B AT828267A AT828267A AT270069B AT 270069 B AT270069 B AT 270069B AT 828267 A AT828267 A AT 828267A AT 828267 A AT828267 A AT 828267A AT 270069 B AT270069 B AT 270069B
Authority
AT
Austria
Prior art keywords
influenza
manufacture
vaccine preparation
injectable vaccine
injectable
Prior art date
Application number
AT828267A
Other languages
English (en)
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Application granted granted Critical
Publication of AT270069B publication Critical patent/AT270069B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT828267A 1966-09-13 1967-09-11 Verfahren zur Herstellung einer injizierbaren Influenzavaccinezubereitung AT270069B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB40770/66A GB1128637A (en) 1966-09-13 1966-09-13 Influenza vaccine

Publications (1)

Publication Number Publication Date
AT270069B true AT270069B (de) 1969-04-10

Family

ID=10416528

Family Applications (1)

Application Number Title Priority Date Filing Date
AT828267A AT270069B (de) 1966-09-13 1967-09-11 Verfahren zur Herstellung einer injizierbaren Influenzavaccinezubereitung

Country Status (9)

Country Link
AT (1) AT270069B (de)
BE (1) BE703831A (de)
DE (1) DE1617357A1 (de)
DK (1) DK116752B (de)
ES (1) ES344982A1 (de)
FR (1) FR6798M (de)
GB (1) GB1128637A (de)
NL (1) NL6712552A (de)
SE (1) SE320764B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4407522A (en) * 1983-03-11 1983-10-04 Hyman Suroff Energy saving ice skate attachment device

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706957D0 (en) 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
GB9820525D0 (en) * 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4407522A (en) * 1983-03-11 1983-10-04 Hyman Suroff Energy saving ice skate attachment device

Also Published As

Publication number Publication date
FR6798M (de) 1969-03-17
ES344982A1 (es) 1968-11-16
DE1617357A1 (de) 1971-03-25
DK116752B (da) 1970-02-09
NL6712552A (de) 1968-03-14
BE703831A (de) 1968-03-13
SE320764B (de) 1970-02-16
GB1128637A (en) 1968-09-25

Similar Documents

Publication Publication Date Title
CH510032A (de) Verfahren zur Herstellung substituierter Chinazolinverbindungen
CH490309A (de) Verfahren zur Herstellung substituierter Biphenylessigsäuren
AT282617B (de) Verfahren zur herstellung der 1-p-chlorbenzoyl-2-methyl-5-dimethylamino-3-indolylessigsaeure
CH484108A (de) Verfahren zur Herstellung von Pyrrylaminoäthanolen
CH503786A (de) Verfahren zur Herstellung einer Emaille-Zubereitung
CH491837A (de) Verfahren zur Herstellung von Methyl- oder Dimethyladamantanen
AT282821B (de) Verfahren zur Herstellung einer antigenfreien Vaccine
AT270069B (de) Verfahren zur Herstellung einer injizierbaren Influenzavaccinezubereitung
CH485731A (de) Verfahren zur Herstellung von 3-Amino-4-carboxamidopyrazol
AT259760B (de) Verfahren zur Herstellung von Influenzavaccinen
CH479626A (de) Verfahren zur Herstellung von Organooxysilanen
CH484016A (de) Verfahren zur Herstellung von Hydrindacenen
CH481087A (de) Verfahren zur Herstellung cyclischer Äther von Cardenolid-Digitoxosiden
CH491064A (de) Verfahren zur Herstellung von Diaceton-L-sorbose
AT285044B (de) Verfahren zur Herstellung einer somatischen Antigenvaccine
CH484063A (de) Verfahren zur Herstellung von gegebenenfalls substituierten a-Amino-a-methylpropionaniliden
CH487177A (de) Verfahren zur Herstellung von Thiaimidazolidinen
CH491857A (de) Verfahren zur Herstellung von Phenoxyaminoalkanolen
CH484155A (de) Verfahren zur Herstellung von 6-Amino-uracil-5-carbonamid-N-sulfonamiden
CH461475A (de) Verfahren zur Herstellung von Cycloheptenderivaten
CH472381A (de) Verfahren zur Herstellung von Monohalogeno- azeto-azetamiden
CH486432A (de) Verfahren zur Herstellung N-acylierter Benzol-m-disulfonamide
CH484860A (de) Verfahren zur Herstellung von substituierten Cyclopent-2-enonen
AT277957B (de) Verfahren zur Herstellung von Alkenonen
CH487860A (de) Verfahren zur Herstellung von Arylsulfonylsemicarbaziden